Regeneron Announces Presentation At the NewsMakers In The Biotech Industry Presented by BioCentury&Thomson Financial/Carson
Businesswire, Wednesday, September 04, 2002 at 13:49
TARRYTOWN, N.Y., Sep 4, 2002 (BUSINESS WIRE) -- Regeneron Pharmaceuticals, Inc. (Nasdaq:REGN) announced today that its presentation at the NewsMakers In The Biotech Industry conference will be available through Regeneron's website.
Leonard S. Schleifer, M.D., Ph.D., President and CEO, will provide an overview of the Company and its clinical programs. Dr. Schleifer will make his presentation from The Millennium Broadway Hotel, New York, New York at 2:30 p.m. (ET) on Thursday, September 5, 2002. The presentation slides may be accessed through the Company's website (www.regn.com on the Events page, under the Investor heading) at the time of the presentation, and they will be archived for 30 days.
Regeneron is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates in clinical trials for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma, and has preclinical programs in other diseases and disorders. Regeneron's platform technologies include Targeted Genomics(TM), Functionomics(TM), and Designer Protein Therapeutics(TM).
Additional information about Regeneron and recent news releases are available on Regeneron's website at www.regn.com. Fax copies of news releases can be obtained from Regeneron's News-on-Demand Service by dialing 800/311-0841. |
